This finding adds yet another degree of complexity to the byzantine puzzle that is the search for a cure for the virus.
June 9, 2017
____________________________________________________________________________________
____________________________________________________________________________________
The resting, or unreplicating, immune cells that are a major
component of the HIV reservoir can clone themselves and give rise to new
latently infected cells capable of producing virus. This finding about
the reservoir’s ability to proliferate reveals yet another factor that
makes curing the virus so extremely difficult.
Latently
infected cells remain under the radar of standard antiretroviral (ARV)
treatment for HIV because such drugs work only in actively replicating
infected cells.
Publishing their findings in The
Journal of Experimental Medicine, researchers drew CD4 cells latently
infected with HIV from 12 people on long-term ARV treatment. They then
grew the cells in the laboratory and exposed them to four rounds of
chemicals to stimulate cell division and proliferation.
After
each round of stimulation, the scientists divided the cell population
into two separate groups, one of which received another round of they
chemicals while the other served as a control. After each treatment,
they measured whether the cells were actively producing virus.
Received
wisdom held that latently infected cells could not proliferate without
releasing active HIV. But in this study, the researchers found that each
round of stimulation caused some of the cells to produce virus, which
suggested that some of the latently infected cells divided without
releasing any virus and retained this ability in the face of subsequent
stimulations.
Genetic sequencing of the viruses
revealed that 57 percent of the viruses had genetic footprints identical
to other virus isolates from the same study participant. This strongly
suggests that the latently infected cells were proliferating and in the
process copying the HIV encoded into their genomes.
“We
knew before that the reservoir is very long-lived,” Robert Siliciano,
MD, PhD, a professor of medicine at Johns Hopkins University School of
Medicine and the study’s lead author, said in a press release, “but what
we didn’t know was how the reservoir was maintained. Now it is clear
that these cells aren’t just sitting there but are dividing and
replenishing themselves.”
In future research, Siliciano
and his team intend to investigate the particular factors that lead
latently infected cells to proliferate. They also hope to develop new
means of studying whether where it is HIV has been integrated into the
cellular genome affects this process.
To read a press release about the study, click here.
To read the study, click here.
Read more articles from POZ, here.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.